Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Platinum Resistance
100%
Chemotherapy
100%
Ovarian Cancer
100%
Chemotherapy Resistance
75%
DNA Repair
75%
PARP Inhibitors (PARPi)
75%
DNA Damage
50%
Platinum-based Chemotherapy
50%
Sequencing Technology
25%
Response to Treatment
25%
Specific Genes
25%
DNA Repair Deficiency
25%
New Drugs
25%
Optimal Surgical Debulking
25%
Cure Rate
25%
Avatar Models
25%
BRCA mutation
25%
Tumor DNA
25%
Base Excision Repair
25%
Cancer Recurrence
25%
Tumor
25%
Recent Advances
25%
DNA Repair Capacity
25%
Best Combination
25%
Cell Death
25%
Response Predictors
25%
Ovarian Cancer Screening
25%
Targeted Therapy
25%
Drug-resistant Cancer
25%
Foundation Medicine
25%
Intracellular Signaling
25%
Cancer Cells
25%
Survival Rate
25%
Patient Will
25%
Effective Treatment
25%
Multiple Therapies
25%
Inpatient Treatment
25%
Medicine and Dentistry
Ovarian Cancer
100%
Chemotherapy
100%
Platinum
100%
DNA Repair
55%
PARP Inhibitor
33%
Tumor
22%
DNA Damage
22%
Combination Therapy
11%
Cancer Recurrence
11%
Base Excision Repair
11%
Targeted Therapy
11%
Malignant Neoplasm
11%
BRCA Mutation
11%
Cancer Cell
11%
Debulking
11%
Cell Death
11%
Lethality
11%
Clinician
11%
Survival Rate
11%
Cancer Treatment
11%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Chemotherapy Regimens
100%
Platinum
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
33%
Malignant Neoplasm
22%
Cancer Recurrence
11%
Lethality
11%
Survival Rate
11%
Combination Therapy
11%
Base
11%